Polypeptide for inhibiting activity of bacillus subtilis transglutaminase (BTG) and its screening method and use
A technology of transglutaminase and Bacillus subtilis, applied in the biological field, can solve problems such as toxicity, low enzyme yield, and no patent publications have been found, and achieve high expression, release inhibition effect, and reduce the effect of toxic effect.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0029] The present invention will be described in further detail below through specific examples. The following examples are only descriptive and not restrictive, and the protection scope of the present invention cannot be limited by this.
[0030] The methods in the following examples are conventional methods unless otherwise specified.
[0031] Streptomyces-derived TG has a signal peptide and a propeptide. Due to the action of the propeptide, the Streptomyces-derived TG is inactive in the cell and cannot function as a cross-linking protein, thereby not damaging the cell. However, BTG derived from Bacillus subtilis has no signal peptide and propeptide, only mature peptides with activity. Therefore, it is hoped that the propeptide of Streptomyces TG can inhibit the activity of BTG.
[0032] The TG propeptide sequences derived from 7 different Streptomyces (S.cinnamoneus, S.caniferus, S.fradiae, S.hygroscopicus, S.mobaraense, S.netropsis, S.platensis) were selected and compared, and t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com